Clinical trials aiming to discover new treatment options with higher effectiveness rates are available for pericardial mesothelioma diagnosed patients willing to explore alternative treatment methods. Although their efficiency has not been accurately assessed yet, immunotherapy and gene therapy are two of the treatment options for this form of cancer, which patients can undergo in clinical trials.

Immunotherapy attempts to improve the response of the immune system to the occurring disease by using antigens such as mesothelin, while gene therapy involves manipulating the patient’s genes in order to repair the defective ones, which allowed pericardial mesothelioma to develop. Even though the efficiency of treatment options available in clinical trials has not been completely demonstrated, since researches are still in progress, such experimental methods can help the patient improve their prognosis in certain cases.